Thoughtful psychiatric care. Portsmouth, NH.
A comprehensive psychiatric practice, built to treat the whole person rather than one diagnosis or one treatment. The same careful, individualized approach applied to every patient.
Spravato® (esketamine) is an FDA-approved nasal spray for treatment-resistant depression — typically for patients who have tried two or more antidepressants without adequate relief. It works on different brain pathways and is administered in-office under physician supervision.
Dr. David Schopick has spent more than 30 years in clinical practice, working with patients navigating mood disorders, anxiety, ADHD, trauma, OCD, and treatment-resistant depression. His approach combines careful diagnostic work with conservative, individualized prescribing.
He sees patients from childhood through adulthood — and has spent his career building the kind of practice where the same physician is there for every appointment, every crisis, and every milestone.
“The patients I see most often are the ones who have already tried other medications. They’ve been through multiple medications, multiple providers, and they’re exhausted. My job isn’t to start over from scratch — it’s to look more carefully at what hasn’t worked and why, and to bring options to the table they may not have had access to yet.”
— David J. Schopick, M.D.We offer telepsychiatry by video for evaluations and ongoing medication management. Spravato® is available in-office for treatment-resistant depression.
HIPAA-compliant video visits for initial evaluations and ongoing medication management. All you need is a smartphone with audio and video capabilities — making it easy to keep appointments from wherever you are. Available to patients whose primary residence is in NH or MA.
The practice is in-network with:
Send us a note. Vicki, our office manager, responds personally.